SHS Capital, the firm dedicated to building European Healthcare Champions, has secured $100K in investment capital. The funding comes as SHS Capital continues its work accelerating the growth of "Mittelstand" and growth-stage companies across the DACH, Benelux, and Nordics regions.
The firm focuses on a broad range of industries, including life science, medical technology, diagnostics, digital health, applied technologies, and industrial biotechnology & pharmaceuticals, while explicitly excluding drug development. SHS Capital operates with high ethical and sustainable standards in its investment approach.















